Logotype for Oncopeptides

Oncopeptides (ONCO) investor relations material

Oncopeptides Investing in Life Science 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Oncopeptides
Investing in Life Science 2025 summary25 Sep, 2025

Company overview and strategy

  • Swedish biotech firm focused on difficult-to-treat cancers, currently commercializing Pepaxi in Europe and developing an innovative pipeline.

  • Employs around 80 people, split between headquarters/R&D in Stockholm and commercial teams in key European markets.

  • Expansion strategy includes direct commercialization in Europe and partnerships in other regions, such as South Korea and Greece.

  • Recent SEK 150 million rights issue was oversubscribed, supporting ongoing commercialization efforts.

  • Aims to expand geographically and through pipeline innovation, targeting SEK 1.5 billion in annual European sales for Pepaxi.

Product and market development

  • Pepaxi treats multiple myeloma, prolonging life with minimal side effects and improving quality of life.

  • Approved in Europe since August 2022, with commercialization underway in Germany, Spain, Italy, and Austria.

  • Included in European treatment guidelines for late-line multiple myeloma, enhancing credibility and adoption.

  • Achieved innovative pricing and national guideline inclusion in Germany and Austria.

  • Market access and price negotiations are ongoing in additional European countries, with phased expansion planned.

Financial performance and growth targets

  • Q2 sales grew 45% over Q1 2025 and 135% year-over-year, marking the third consecutive quarter of 30%+ growth.

  • Profitability targeted by 2026, driven by key markets representing about 50% of total market potential.

  • Multiple revenue streams from direct sales, partnerships, and pipeline innovations aim to derisk and boost growth.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Oncopeptides earnings date

Logotype for Oncopeptides
Q3 20255 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Oncopeptides earnings date

Logotype for Oncopeptides
Q3 20255 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Oncopeptides AB, a biotech company, focuses on the development of therapies for patients with cancer. The company's lead drug candidate is melflufen, which has received orphan drug designation from the European Commission, as well as from the FDA for the treatment of multiple myeloma. Its product pipeline also comprises peptide-drug conjugates that are in preclinical stage development for hematological malignancies and solid tumors. The company is based in Stockholm, Sweden

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage